Life Sciences Investment Programme
We seek best-in-class fund managers with a UK focus.
Through the Life Sciences Investment Programme, British Patient Capital has been allocated an additional £200m to make cornerstone commitments to later stage life sciences venture growth funds. This is expected to attract at least a further £400m of private investment, ensuring the UK continues to be a world leader in health and life sciences innovation.
British Patient Capital intends to invest between £50 and £100 million in each successful fund.
What we look for
- Dedicated life sciences focus
- Funds providing later-stage capital
- UK presence in investment team
- Minimum target fund size of £250m
- Focus on funding UK companies
Find out more
For further information please see our Request for Proposals
If you have any queries please contact LSIPproposals@bpcinv.co.uk